GENESIS Tech Transfer Boost invests €50,000 in the funding round of Ownmed Innovation, wh... 23/05/2024 Healthcare Access to innovation Financing Ownmed Innovation's technology provides an alternative to ostomy bags, allowing patients to have greater autonomy and... Partners - GENESIS Biomed
Cellab CDMO obtains a GMP certification for advanced therapy product manufacturing 22/05/2024 Healthcare Access to innovation Personalized medicine Advanced therapies The Spanish Agency for Medicines and Health Products (AEMPS) has certified compliance with the European Union Good... Partners - Cellab
Preclinical studies validate the potential of ApTOLL to reduce inflammation and regenerate... 21/05/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies ApTOLL shows potential for slowing the progression of multiple sclerosis (MS) in preclinical animal studies. Partners - AptaTargets
AMSbiopharma presents a major breakthrough with the analysis of nitrosamines in active pha... 21/05/2024 Healthcare Access to innovation Nitrosamines represent a significant health risk, being potentially carcinogenic and a major concern in pharmaceutical... Partners - AMSbiopharma
#NewAseBioMember | “This partnership gives us the possibility to establish key contacts an... 20/05/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Meet Kirsch Pharma, our new member. We talked to its Raquel Márquez Duro, Key Account Mánager de España y Portugal. AseBio - Kirsch Pharma España
Biotechnology revolutionizes advances against obesity: enhanced understanding, more accura... 18/05/2024 Healthcare Access to innovation To address how biotechnology is enabling progress in combating obesity from various perspectives, and in celebration of... AseBio
#AseBioID24 | “Being present at Investor Day gives you wings to visualize, work and promot... 08/05/2024 Healthcare Access to innovation Advanced therapies Financing Hector Olabegogeaskoetxea Narbaiza, CEO of MONDRAGON Health, Silver Sponsor of AseBio Investor Day, analyzes the biotech... AseBio
Oryzon reports financial results and corporate update for quarter ended March 31, 2024 07/05/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies Financing Finalizing full data analysis from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD)... Partners - Oryzon Genomics
Creation of new 3D liver cell models for research 30/04/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies The main objective of the project is the creation of innovative in vitro models using microencapsulation of human liver... Partners - BeCytes Biotechnologies
Five Galician biotechs attend 'Swiss Biotech Day' with Bioga to explore ways of collaborat... 29/04/2024 Healthcare Access to innovation International The conference held in Switzerland is one of Europe's benchmark events in the biotechnology sector, attracting... Partners - BIOGA
